Authors
Latest:
Bispecific Antibodies: The Next Generation of ImmunotherapyAdvances in biotechnology have improved the production and recombination of antibodies, leading to improvements in monoclonal antibody therapies.
Latest:
Adherence-Aiding Solutions: Scalable, Meaningful, and AffordableHealth care organizations harness technology in their quest to boost medication adherence.
Latest:
Diabetes: New and Emerging TherapiesApproximately 29.1 million individuals in the United States have diabetes, and an estimated 8.1 million cases are undiagnosed.
Latest:
Pharmacist Burnout: A Cry for a Transformative Approach to Traditional Pharmacy PracticePharmacists must juggle the delicate balance of integrating clinical services into traditional dispensing environments, while being forced into performance metrics set forth by corporate entities.
Latest:
Tech Duties Increase in Health SystemsTechnicians pick up administrative tasks so pharmacists can spend more time on direct patient care.
Latest:
Antimicrobial Stewardship: A Primer for Hospital PharmacistsThe CDC has reported that 20% to 50% of all antibiotics prescribed in US acute care hospitals are either unnecessary or inappropriate, resulting in avoidable adverse effects, bacterial resistance, and an increased incidence of infection.
Latest:
Repatha: A Lipid-lowering Monoclonal AntibodyEvolocumab, when used with diet, can be used as monotherapy or in combination with other lipid-lowering agents for the prevention of cardiovascular events.
Latest:
Buprenorphine Treatment Linked to Depression, Sleep DisruptionOpioid therapies are often prescribed for sleep disturbance due to their effect on multiple neurochemical pathways associated with sleep.
Latest:
Electronic Prescribing of Controlled Substances: A Tool to Help Promote Better Patient CareThis study presents the first information available regarding enablement and use by state and area characteristics of electronic prescribing of controlled substances by prescribers and pharmacy systems in from an e-prescribing network.
Latest:
Together Beyond COVID-19: A Look at the Future of the Pharmaceutical IndustryIn a short time, COVID-19 has increased our dependency on technology and pharmaceutical companies are actively investigating this digital transformation.
Latest:
340B Compliance: The Medicaid Exclusion File and Prevention of Duplicate DiscountsHealth care providers participating in the 340B program are prohibited from contributing to duplicate discounts, or the scenario that exists when a manufacturer provides a discounted 340B price and a rebate to Medicaid for the same drug.
Latest:
Antimicrobial Stewardship at the Tipping PointAntimicrobial stewardship programs have been around for some time. However, a tipping point has yet to be achieved where most hospitals and long-term care facilities have effective programs.
Latest:
Trends Associated with Implementing and Lifting a Pregabalin Step Therapy PolicyThis study examined the impact of a pregabalin step therapy policy on utilization and medical costs in Humana’s Medicare and commercial plans.
Latest:
Seven Essential Points to Position Specialty Pharmacies for Limited-Distribution AgentsPosition your specialty pharmacy to access limited distribution drugs.
Latest:
Growth Hormone Therapy Guidelines: Clinical and Managed Care PerspectivesCurrent treatment guidelines utilized by healthcare provider organizations and managed care organization insurance coverage policies for growth hormone therapy are reviewed.
Latest:
Jumping Through Hoops and Over HurdlesGaining approval from insurance companies for highly effective new hepatitis C virus treatments is fraught with challenges for patients.
Latest:
Acute Coronary Syndrome: How to Empower PatientsPatients with a new diagnosis of acute coronary syndrome often do not know a great deal about their disease, its treatment, or the lifestyle changes needed to prevent recurrence.
Latest:
Recent Trends in the Treatment of Chronic Hepatitis CThis article is an early utilization review of newer, more effective, and more costly regimens for the treatment of hepatitis C.
Latest:
Repatha Gets Early Thumbs Down by Britain's NICEThe action by NICE highlights discussion on both sides of the Atlantic about the cost of PCSK9 inhibitors, which lower LDL cholesterol.
Latest:
COPD: Improving Disease ManagementEffective management of COPD can improve quality of life for patients and help reduce rehospitalizations.
Latest:
Specialty Drugs: Year in Review 2017 Part IIThe second part of a comprehensive review of the specialty pharmaceuticals approved by the FDA in 2017.
Latest:
Acute Pain Management in the General PopulationAcute pain is one of the most common complaints that lead Americans to access the health care system, resulting in more than 115 million emergency department visits each year.
Latest:
Tuberculosis: The Consuming PlagueThe development of multidrug-resistant and extensively drug-resistant tuberculosis in recent decades has made treatment challenging.
Latest:
Patient Preference for Treatment Administration in Cystic FibrosisThis study assesses the preferences of patients with cystic fibrosis for treatments that differ in the mode of administration.
